脊椎增强术市场规模、份额和成长分析（按手术类型、器械类型、材料类型、应用、最终用户和地区划分）—产业预测（2026-2033 年）

全球椎体增强市场规模预计在 2024 年达到 32.9 亿美元，从 2025 年的 34.6 亿美元成长到 2033 年的 52 亿美元，在预测期（2026-2033 年）内复合年增长率为 5.2%。

全球椎体增强术市场的主要驱动力是骨质疏鬆症和脊椎疾病的日益增加以及人口老化。微创手术技术的进步进一步加速了市场动态。更严格的监管指南确保了病人安全和手术有效性，增强了医生和病人对所用材料品质的信心。不断增加的研发投入催生了创新医疗设备，这些器械将椎体高度恢復和骨水泥注射等多种功能整合到一个统一的系统中。随着技术创新提高效率并降低医疗成本，对微创脊椎手术的需求不断增长。此外，专科诊所和门诊手术中心的增加扩大了病患的就医管道，而病患对先进治疗方案的偏好变化也进一步推动了市场扩张。

推动全球椎体增强市场发展的因素

全球人口老化加剧是椎体成形术市场的主要驱动因素。骨质疏鬆症在老年族群中十分常见，导致骨骼脆弱，骨折风险增加。因此，这种人口结构变化导致椎体压迫性骨折（VCF）的发生率上升，进而推动了对后凸成形术和椎体后凸成形术等有效治疗方法的需求。这些手术不仅可以缓解疼痛，还能改善VCF患者的活动能力。随着老年人口的持续增长，对椎体成形术治疗的持续需求预计将推动市场成长。

全球椎体增强治疗市场的限制因素

椎体强化手术的高昂费用是其市场扩张的一大障碍。这笔费用涵盖医疗设备、手术介入、住院治疗和术后护理等各个面向。对于部分患者而言，尤其是那些居住在医疗保险覆盖不足或社会经济地位较低的地区的患者，这些费用可能难以承受，导致他们无法接受治疗。因此，经济压力可能导致治疗延误，或促使患者选择费用较低的保守治疗方案，例如止痛药或矫正器具。椎体强化手术的高昂费用阻碍了其市场渗透，限制了此类治疗方法的广泛应用。

全球椎体增强术市场趋势

全球椎体增强术市场正经历着向微创治疗的显着转变，这反映了医疗保健领域的整体趋势。椎体成形术和椎体增强术等技术因其切口小、出血少、住院时间短等优势而备受关注。科技进步不断提升这些手术的安全性和精准度，与外科医师和病患对微创治疗方案日益增长的需求不谋而合。这种日益增长的偏好正在推动器材研发的创新，最终带来更佳的临床疗效，并促进市场的强劲成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 一手和二手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 关键成功因素
• 影响市场的因素
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 用例
• 技术评估
• 监管环境

全球脊椎增强术市场规模（按手术类型和复合年增长率划分）（2026-2033 年）

• 椎体成形术
• 后凸成形术

全球脊椎增强市场规模（按器材类型和复合年增长率划分）（2026-2033 年）

• 椎体成形术装置
• 椎体成形术装置
• 骨通路装置
• 其他的

全球脊椎增强市场规模（按材料类型和复合年增长率划分）（2026-2033 年）

• 水泥
• 生物材料
• 骨移植材料
• 其他的

全球脊椎增强术市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 骨质疏鬆症
• 椎体骨折
• 瘤

全球脊椎增强市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

• 医院
• 门诊手术中心（ASC）
• 专科诊所
• 创伤中心

全球脊椎增强术市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • GCC
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

  主要企业简介

  • 美敦力公司（爱尔兰）
  • 强生公司（美国）
  • 史赛克公司（美国）
  • Globus Medical Inc.（美国）
  • Zimmer Biomet Holdings, Inc.（美国）
  • NuVasive公司（美国）
  • Orthofix Medical Inc.（美国）
  • B. Braun Melsungen AG（Aesculap）（德国）
  • Merit Medical Systems, Inc.（美国）
  • IZI医疗产品（美国）
  • Zavation（美国）
  • RONTIS（瑞士）
  • BPB Medica Srl（义大利）
  • 斯皮内尔特（瑞士）
  • SeaSpine（美国）
  • Accutus Medical（美国）
  • 安全骨科（法国）

结论与建议

Global Vertebral Augmentation Market size was valued at USD 3.29 Billion in 2024 and is poised to grow from USD 3.46 Billion in 2025 to USD 5.2 Billion by 2033, growing at a CAGR of 5.2% in the forecast period (2026-2033).

The global vertebral augmentation market is primarily driven by the increasing prevalence of osteoporosis and spinal disorders, alongside an aging population. Advancements in minimally invasive surgical techniques are further enhancing market dynamics. Stricter regulatory guidelines ensure patient safety and procedural effectiveness, instilling confidence among both physicians and patients regarding the quality of materials used. Increased investment in research and development is leading to innovative medical devices that streamline various functions, such as vertebral height restoration and cement injection, into unified systems. As technological innovations improve efficiency and reduce healthcare costs, the demand for minimally invasive spinal procedures rises. Additionally, the growth of specialty clinics and ambulatory surgical centers expands patient access, while shifting preferences towards advanced treatment options drive further market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vertebral Augmentation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vertebral Augmentation Market Segments Analysis

Global Vertebral Augmentation Market is segmented by Procedure Type, Device Type, Material Type, Application, End-User and region. Based on Procedure Type, the market is segmented into Vertebroplasty and Kyphoplasty. Based on Device Type, the market is segmented into Vertebroplastic Devices, Kyphoplastic Devices, Bone Access Devices and Others. Based on Material Type, the market is segmented into Cement, Biomaterials, Bone Grafts and Others. Based on Application, the market is segmented into Osteoporosis, Spinal Fractures and Tumors. Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Trauma Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Vertebral Augmentation Market

The expanding elderly population worldwide serves as a significant catalyst for the vertebral augmentation market. As osteoporosis frequently affects older individuals, it leads to an increased risk of fractures due to bone weakening. Consequently, this demographic shift contributes to a higher incidence of vertebral compression fractures (VCFs), which in turn drives the demand for effective treatment options like kyphoplasty and vertebroplasty. These procedures not only alleviate pain but also improve mobility for patients suffering from VCFs. As the number of elderly individuals continues to increase, the ongoing demand for vertebral augmentation treatments is expected to propel market growth.

Restraints in the Global Vertebral Augmentation Market

The high cost associated with vertebral augmentation procedures presents a substantial obstacle to market expansion. This financial burden encompasses expenses for the device, surgical intervention, hospitalization, and post-operative care. Many patients, particularly those in regions with inadequate healthcare coverage or lower socioeconomic conditions, may find these costs prohibitive. Consequently, the financial pressure can lead to delays in receiving treatment or the adoption of less expensive, more conservative options such as pain relief medications or brace usage. Ultimately, the significant expense linked to vertebral augmentation procedures hinders market penetration and restricts broader acceptance of these interventions.

Market Trends of the Global Vertebral Augmentation Market

The Global Vertebral Augmentation market is experiencing a notable shift towards minimally invasive treatments, underscoring a broader trend in the medical field. Techniques like kyphoplasty and vertebroplasty are gaining traction due to their advantages, including reduced incisions, lower blood loss, and shorter hospital stays. Advancements in technology are enhancing the safety and precision of these procedures, aligning with the increasing demand from both surgeons and patients for less invasive options. This growing preference is fostering innovation in device development, ultimately leading to improved clinical outcomes and contributing to the robust expansion of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• Pestel Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape

Global Vertebral Augmentation Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Vertebroplasty
• Kyphoplasty

Global Vertebral Augmentation Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Vertebroplastic Devices
• Kyphoplastic Devices
• Bone Access Devices
• Others

Global Vertebral Augmentation Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Cement
• Biomaterials
• Bone Grafts
• Others

Global Vertebral Augmentation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Osteoporosis
• Spinal Fractures
• Tumors

Global Vertebral Augmentation Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Trauma Centers

Global Vertebral Augmentation Market Size & CAGR (2026-2033)

• North America (Procedure Type, Device Type, Material Type, Application, End-User)
  • US
  • Canada
• Europe (Procedure Type, Device Type, Material Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Procedure Type, Device Type, Material Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Procedure Type, Device Type, Material Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Procedure Type, Device Type, Material Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Aesculap)(Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IZI Medical Products (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zavation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RONTIS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPB Medica S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spineart (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeaSpine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accutus Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Safe Orthopaedics (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations